Activation by Mallotus compounds of KCNQ1 alone and in complexes with KCNEs may contribute to its purported therapeutic effects in GI and cardiovascular disorders and diabetes given the known roles of KCNQ1 in these systems (De Silva et al., 2018; Manville and Abbott, 2018). This evidence concerns the gene KCNQ1 and diabetes mellitus.